Institutional shares held 67.8 Million
1.68M calls
91.8K puts
Total value of holdings $71.9M
$1.78M calls
$97K puts
Market Cap $82.4M
77,724,600 Shares Out.
Institutional ownership 87.28%
# of Institutions 130


Latest Institutional Activity in CHRS

Top Purchases

Q1 2025
Sg Americas Securities, LLC Shares Held: 65.3K ($69.3K)
Q1 2025
Pallas Capital Advisors LLC Shares Held: 12.8K ($13.5K)
Q1 2025
Cambridge Investment Research Advisors, Inc. Shares Held: 51.8K ($54.9K)
Q1 2025
Wealth Enhancement Advisory Services, LLC Shares Held: 33.2K ($35.2K)
Q4 2024
Point72 Asset Management, L.P. Shares Held: 5.28M ($5.6M)

Top Sells

Q1 2025
Rhumbline Advisers Shares Held: 148K ($157K)
Q4 2024
Rubric Capital Management LP Shares Held: 5.26M ($5.57M)
Q4 2024
Barclays PLC Shares Held: 300K ($318K)
Q4 2024
Goldman Sachs Group Inc Shares Held: 535K ($567K)
Q4 2024
Two Sigma Investments, LP Shares Held: 134K ($142K)

About CHRS

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma in China; Bevacizumab biosimilar; and CHS-1420, an anti-TNF product candidate, as an adalimumab biosimilar; Ranibizumab biosimilar. Coherus BioSciences, Inc. has license agreements with Selexis SA; AbbVie, Inc.; Pfizer, Inc.; Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; and Junshi Biosciences. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was incorporated in 2010 and is headquartered in Redwood City, California.


Insider Transactions at CHRS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
36.3K Shares
From 3 Insiders
Payment of exercise price or tax liability 36.3K shares

Track Institutional and Insider Activities on CHRS

Follow Coherus BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CHRS shares.

Notify only if

Insider Trading

Get notified when an Coherus Bio Sciences, Inc. insider buys or sells CHRS shares.

Notify only if

News

Receive news related to Coherus BioSciences, Inc.

Track Activities on CHRS